Rebecca Moroose

Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer

Aditya Bardia, Ingrid A. Mayer, Linda T. Vahdat et al. · New England Journal of Medicine · 2019 · 850 citations

Medicine, Oncology, Pharmacology +17

Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer

Aditya Bardia, Ingrid A. Mayer, Jennifer R. Diamond et al. · Journal of Clinical Oncology · 2017 · 409 citations

Medicine, Oncology, Pharmacology +12

Ribociclib plus Endocrine Therapy in Early Breast Cancer

Dennis J. Slamon, Oleg Lipatov, Zbigniew Nowecki et al. · New England Journal of Medicine · 2024 · 357 citations

Medicine, Oncology, Pharmacology +15

Comparison of bovine and porcine heparin in heparin antibody formation after cardiac surgery

John L. Francis, George J. Palmer, Rebecca Moroose et al. · The Annals of Thoracic Surgery · 2003 · 146 citations

Medicine, Surgery, Hemostasis +3

Ribociclib and endocrine therapy as adjuvant treatment in patients with HR+/HER2- early breast cancer: Primary results from the phase III NATALEE trial.

Dennis J. Slamon, Daniil Stroyakovskiy, Denise A. Yardley et al. · Journal of Clinical Oncology · 2023 · 139 citations

Medicine, Oncology, Pharmacology +17